Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017 by Linda A. Johnson
Viagra goes generic: Pfizer to launch own little white pill
This Monday, Dec. 4, 2017 photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. The drugmaker is launching its own cheaper generic version of Viagra rather than lose sales when its impotence pill gets its first generic competition. (AP Photo/Richard Drew)

The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first generic competition next week.

Pfizer Inc. will begin selling the white pill at half the $65-a-pill retail price on Monday, when its patent-protected monopoly ends. Generic maker Teva Pharmaceuticals can start selling its version then, but isn't disclosing the price.

Many more generics go on sale next summer, which will steadily slash the price of generics, possibly by 90 percent.

"Patients are paying fortunes. When generic Viagra comes out, they will be very happy," said Dr. Nachum Katlowitz, a urologist at New York's Staten Island University Hospital.

Launched in 1998, Viagra was the first pill for impotence. It transformed a private frustration for many aging men into a publicly discussed medical condition with an easy treatment, far more appealing than options like penile injections and implants. Pfizer's early TV ads for the little blue pill even coined the term erectile dysfunction, ED for short.

Eli Lilly's Cialis came out in 2003 and now dominates the U.S. market with on-demand pills and daily, low-dose ones. Viagra is a close second.

Viagra goes generic: Pfizer to launch own little white pill
This Monday, Dec. 4, 2017 photo shows Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. The drugmaker is launching its own cheaper generic version of Viagra rather than lose sales when its impotence pill gets its first generic competition. (AP Photo/Richard Drew)

Pfizer says its market research shows 20 percent of customers are loyal to Viagra. So rather than give up sales to generic makers as brand-name drugmakers once routinely did, the company is selling its own generic and also fighting to keep men on its blue pills.

"We believe that the story for Viagra isn't done. It's just going to be a new chapter," said Jim Sage, president of U.S. brands for Pfizer Essential Health, which sells its older medicines.

In January, the drugmaker will offer two new discount programs and increase its copayment card discounts. Uninsured men can get brand-name Viagra half off through an innovative online home delivery program, Pfizer Direct. Many insured patients will be able to get a month's prescription—typically six to 10 pills, depending on plan limits—for as little as a $20 copayment.

"This is the most comprehensive pricing and marketing response I've seen to a generic," said Erik Gordon, a pharmaceuticals analyst at the University of Michigan's business school. "It's unprecedented."

Gordon thinks Pfizer's reduced prices will retain some patients and attract others who buy pills, often counterfeits, from the internet.

Viagra goes generic: Pfizer to launch own little white pill
In this Dec. 1, 2017 photo, patient Daniel Lobello, left, speaks with Dr. Matthias Hofer, a urologist at Northwestern Memorial Hospital in Chicago. Lobello, 60, thinks a lot of men probably would start using cheaper generic or brand-name Viagra. "It's great" that the prices are getting cut, said the electrical inspector, "because it's something men need." (AP Photo/Teresa Crawford)

Dr. Matthias Hofer, a urologist at Northwestern Memorial Hospital in Chicago, said some of his insured patients who take Viagra wouldn't want a generic. "They will be ecstatic if they can save money and get the brand product from Pfizer," he said.

Last year, more than 12 million prescriptions for Viagra and Cialis were filled in the U.S., generating a combined $3 billion in sales, according to health data and clinical research company IQVIA. However, prescriptions have dropped more than 20 percent since 2012, as repeated price hikes put the pills out of reach for many men lacking good insurance.

According to health information analytics firm Elsevier, over just the past decade, retail prices jumped from about $10 to $62 per pill for Viagra and from $11 to $61 for Cialis. Pharmacies and other middlemen add a few dollars more per pill.

Generic Viagra, called sildenafil, will become even more affordable starting June 11, when more versions go on sale.

"Many patients already know it's going generic and they want it," said Aracely Pena, a medical assistant at San Diego Sexual Medicine.

Viagra goes generic: Pfizer to launch own little white pill
This Dec. 1, 2017 photo, shows Dr. Matthias Hofer, a urologist at Northwestern Memorial Hospital in Chicago. Hofer says he has some insured patients taking Viagra who wouldn't want a generic. "They will be ecstatic if they can save money and get the brand product from Pfizer," he said, adding that half his patients can't afford Viagra and some just go without sex.(AP Photo/Teresa Crawford)

Cialis and Levitra, another pill launched in 2003, get their own next fall.

In the meantime, some doctors specializing in sexual dysfunction have found other options. Some prescribe generic Revatio, the blood pressure pill Pfizer was testing when older patients reported stronger erections as a side effect. It contains one-fifth the sildenafil dose in Viagra and costs as little as $1 per .

Northwestern's Hofer arranges for his patients to receive made-to-order pills from a couple of specialty pharmacies.

Viagra goes generic: Pfizer to launch own little white pill
This Monday, Dec. 4, 2017 photo shows Pfizer's generic version of Viagra, sildenafil citrate, at the company's headquarters in New York. The drugmaker is launching its own cheaper generic version of Viagra rather than lose sales when its impotence pill gets its first generic competition. (AP Photo/Richard Drew)

Daniel Lobello, 60, is satisfied with those pills but thinks a lot of men probably would use cheaper generic or brand-name Viagra.

"It's great" that the prices are getting cut, said the West Chester, Illinois, electrical inspector, "because it's something men need."

Explore further: Pfizer, Teva reach deal to allow generic Viagra

Related Stories

Pfizer, Teva reach deal to allow generic Viagra

December 17, 2013
Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.

Can't buy love? Drug price hikes put sex beyond reach

December 5, 2016
Imagine not being able to afford one of life's great pleasures—sex.

Viagra to be sold without prescription in Britain

November 29, 2017
Britain is to become the first country in the world where the erectile disfunction drug Viagra can be bought without the need for a doctor's prescription from 2018, its maker Pfizer said.

Viagra ads target women for first time

September 30, 2014
The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.

Pfizer considers consumer business sale

October 10, 2017
Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription.

Thailand to sell generic Viagra drug: officials

September 26, 2012
Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.

Recommended for you

US approves first generic competitor to Mylan's EpiPen

August 16, 2018
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

August 7, 2018
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...

Unwise opioids for wisdom teeth: Study shows link to long-term use in teens and young adults

August 7, 2018
Getting wisdom teeth removed may be a rite of passage for many teens and young adults, but the opioid painkiller prescriptions that many of them receive could set them on a path to long-term opioid use, a new study finds.

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

August 1, 2018
A study led by Columbia University's Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.